Main content

    Colorectal / Anal Cancer Clinical Trials

    CPMC Cancer Services

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Trials

    Title: A Phase 2 Clinical Trial of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Microsatellite High (MSI-H) Colon Cancer
    Description: This study is to examine if Nivolumab alone or in combination with Ipilimumab will demonstrate a meaningful objective response rate in patients with recurrent and metastatic colon cancer who also have a specific biomarker in their tumors
    Investigators: Ari Baron, MD
    Eligibility: Male & female subjects, 18 y/o and older, with histologically confirmed colorectal cancer
    Status: Please contact site for study status
    Contact: Brenda Eng, 415-600-1775, Email: about Study BMS CA209-142

    • Updated 11/2017

    Back to top